Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation

Sponsor
Hospital Israelita Albert Einstein (Other)
Overall Status
Completed
CT.gov ID
NCT04695301
Collaborator
(none)
25
1
2
15
1.7

Study Details

Study Description

Brief Summary

COVID-19, an acute respiratory disease caused by coronavirus-2 (SARS-CoV-2), and in most cases, causes mild to moderate symptoms of fever, cough and dyspnea. However, a not insignificant portion, given the total number of people affected, will present symptoms of severe acute respiratory failure and multiple organ failure, requiring hospitalization under intensive care, use of mechanical ventilation, prolonged period of immobilization and, consequently, physical, cognitive and psychological damage, which may affect survivors for a long period after hospitalization. All of these factors are known to have an impact on various areas of life: personal, social and economic, which makes the need for continued specific care after hospital discharge relevant. In this context, the role of rehabilitation programs is fundamental, aiming not only at a safer dehospitalization, but also at the continuity of care with the objective of restoring the biopsychosocial skills of these individuals, allowing functional independence for activities of daily life and a shorter return physical and social activities performed before the disease. However, the big challenge for the health system is how to offer this on a large scale. Therefore, knowing the clinical and functional profile of these patients at discharge and verifying the viability of a digital platform for rehabilitation and monitoring of these patients is the first step to allow the creation of a new form of continuity of care and access to affected patients with serious diseases such as COVID-19 and other syndromes capable of generate functional impairment. Therefore,the investigators objective is to characterize and monitor the functional profile and exercise capacity of patients affected by COVID-19 at the hospital discharge, as well as to verify the viability and compliance of patients to the use of a digital platform for the application of a distance rehabilitation program.

Condition or Disease Intervention/Treatment Phase
  • Other: Rehabilitation protocol through a digital platform
N/A

Detailed Description

The investigators proposal is to characterize and evaluate the impact of the disease on the clinical, functional and social aspects in these patients affected by COVID-19 and to propose the continuity of specific care after hospital discharge with a physical rehabilitation program through a digital platform, remotely for a period of 3 months. The proposed hypothesis is that patients convalescing from COVID-19 and undergoing the rehabilitation program will have a gain in functional skills and quality of life. The professional team involved in this study will be responsible for managing, monitoring and evaluating the participating patients and monitoring the performance of the proposed functional exercises.

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Men and women affected by COVID-19, over 18 years of age, admitted to HIAE partner hospitals who have been in hospital for more than 10 days or in need of treatment in semi-intensive or intensive care units will be selected. Follow-up will be carried out for 3 months, with remote reevaluations. During this period, the rehabilitation program will be offered for 3 months, through a digital platform.Men and women affected by COVID-19, over 18 years of age, admitted to HIAE partner hospitals who have been in hospital for more than 10 days or in need of treatment in semi-intensive or intensive care units will be selected. Follow-up will be carried out for 3 months, with remote reevaluations. During this period, the rehabilitation program will be offered for 3 months, through a digital platform.
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation
Actual Study Start Date :
Jul 1, 2020
Actual Primary Completion Date :
Jul 1, 2021
Actual Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: digital platform rehabilitation

Rehabilitation program through a digital platform for 3 months

Other: Rehabilitation protocol through a digital platform
During 3 months the patients will participate in a rehabilitation program through a digital platform

Experimental: control group

Patients without access to technology will do the exercises using booklets and will compose the control group

Other: Rehabilitation protocol through a digital platform
During 3 months the patients will participate in a rehabilitation program through a digital platform

Outcome Measures

Primary Outcome Measures

  1. Characterize the clinical function profile of patients affected by COVID-19 [3 months]

    Characterize the clinical functional profile of patients affected by COVID-19 by data from medical records

  2. Characterize the exercise capacity of patients affected by COVID-19 [3 months]

    Characterize the exercise capacity of patients affected by COVID-19 by 2-minute step test

Secondary Outcome Measures

  1. Assess clinical and demographic data [3 months]

    Assess clinical and demographic data

  2. Assess functional level at hospital discharge [3 months]

    Assess functional level at hospital discharge and 3 months after discharge by physical test

  3. Assess patient compliance of the rehabilitation program using the digital platform [3 months]

    Assess patient compliance of the rehabilitation program using the digital platform checking your adherence to the program

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Men and women affected by COVID-19

  • over 18 years of age, admitted to HIAE partner hospitals

Exclusion Criteria:
  • presence of a physical or cognitive condition that makes it impossible or contraindicated to perform the 2-minute stride test and perform the proposed exercises.

  • Patients with a more severe clinical and functional profile,

  • Pregnant women

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIEP) São Paulo Brazil 05652-000

Sponsors and Collaborators

  • Hospital Israelita Albert Einstein

Investigators

  • Principal Investigator: Luciana D Matos, MD,PhD, Hospital Israelita Albert Einstein

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital Israelita Albert Einstein
ClinicalTrials.gov Identifier:
NCT04695301
Other Study ID Numbers:
  • 34170820.0.1001.0071
First Posted:
Jan 5, 2021
Last Update Posted:
Feb 11, 2022
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospital Israelita Albert Einstein
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 11, 2022